임신 중 nifedipine을 피해야 할까요? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

nifedipine은 임신 중 안전한가요?

Nifedipine is a systemic pharmaceutical (a dihydropyridine Ca2+ channel blocker) with evidence of fetal exposure: PBPK and clinical studies report substantial transplacental transfer (cord:maternal ratios ≈ ~1 in modelling and clinical measurements), and supplier safety data sheets list reproductive toxicity H361 (suspected of damaging fertility or the unborn child). Because ECHA-harmonised H360 classification was not identified but H361 is reported in SDS/registrations, hazard is scored as 'suspected' (h=2); mechanism is 'demonstrated' (m=2) because placental transfer and pharmacodynamic effects on uteroplacental blood flow are reported; topical cosmetic exposure is likely low but systemic if used as a drug, so for cosmetic topical use exposure is low (e=1). (Sources: PBPK and placental studies, systematic reviews and SDSs.).

nifedipine은 모유 수유 중 안전한가요?

Nifedipine is excreted into breastmilk in measurable but generally small amounts and is commonly considered compatible with breastfeeding in clinical guidance; supplier SDSs list reproductive toxicity H361 which supports a suspected reproductive hazard (h=2). Mechanistically, milk transfer is documented (so m=1–2), but adverse effects in infants are not robustly reported in the clinical literature; for topical cosmetic use exposure is expected to be low (e=1).

nifedipine은 아기 피부에 안전한가요?

There is no infant-specific dermal hazard data for 0–3 yr; nifedipine is systemically active and can cross placenta / enter milk, so parental systemic concern remains (h=2). For baby skin, because infants have higher skin absorption and the parent compound is moderately lipophilic (not completely non-absorbable), increase exposure score by +1 relative to adult topical use (adult e=1 → infant e=2). No direct evidence supports increasing hazard or mechanism beyond adult data in absence of infant-specific studies.

VeriMom은 nifedipine을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 nifedipine을 20/100 (높은 위험)로 평가합니다.

임신 중 nifedipine 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.